SEC Comment Letter for AXCAN PHARMA INC (CIK 0001116094) — Oct 6, 2005

AXCAN PHARMA INC (CIK 0001116094)
Date: Oct. 6, 2005 · CIK: 0001116094 · Accession: 0000000000-05-051440

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-30860

Date

October 6, 2005

Author

Kevin Woody

Form

UPLOAD

Company

AXCAN PHARMA INC (CIK 0001116094)

Letter

Mail Stop 0610 Via Facsimile and U.S. Mail October 6, 2005 Jean Vezina Vice President, Finance and Chief Financial Officer Axcan Pharma Inc. 597 Laurier Blvd., Mont St-Hilaire Quebec, Canada J3H 6C4

Re: Axcan Pharma Inc. Form 40-F for the fiscal year ended September 30, 2004 Filed January 21, 2005 File No. 000-30860

Dear Mr. Vezina:

We have completed our review of your Form 40-F and have no further comments at this time.

Sincerely,
Kevin Woody
Branch Chief

Show Raw Text

<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

Mail Stop 0610
Via Facsimile and U.S. Mail

								October 6, 2005

Jean Vezina
Vice President, Finance and
Chief Financial Officer
Axcan Pharma Inc.
597 Laurier Blvd.,
Mont St-Hilaire
Quebec, Canada J3H 6C4

      Re:	Axcan Pharma Inc.
		Form 40-F for the fiscal year ended September 30, 2004
		Filed January 21, 2005
		File No. 000-30860

Dear Mr. Vezina:

	We have completed our review of your Form 40-F and have no
further comments at this time.

								Sincerely,

								Kevin Woody
								Branch Chief

</TEXT>
</DOCUMENT>

SecProbe.io